Table 5 Drug susceptibility analysis according to OVOL1
From: Lysine lactylation (Kla) might be a novel therapeutic target for breast cancer
Drug | cor | pvalue |
|---|---|---|
Elesclomol | 0.4850 | 0.0001 |
SR16157 | 0.4267 | 0.0007 |
bisacodyl, active ingredient of viraplex | 0.4052 | 0.0013 |
Fluorouracil | 0.3687 | 0.0037 |
Fulvestrant | 0.3632 | 0.0043 |
By-Product of CUDC-305 | 0.3595 | 0.0048 |
Acetalax | 0.3547 | 0.0054 |
Carboplatin | -0.3364 | 0.0086 |
Simvastatin | -0.3099 | 0.0160 |
Staurosporine | -0.2887 | 0.0253 |
kahalide f | 0.2852 | 0.0272 |
Arsenic trioxide | -0.2836 | 0.0281 |
Bleomycin | -0.2795 | 0.0306 |
Tegafur | 0.2792 | 0.0307 |
Raloxifene | 0.2723 | 0.0353 |
Benzimate | 0.2702 | 0.0368 |
Midostaurin | -0.2675 | 0.0388 |
Pyrazoloacridine | 0.2671 | 0.0391 |
Cisplatin | -0.2656 | 0.0403 |
Cordycepin | 0.2624 | 0.0428 |
Testolactone | -0.2562 | 0.0481 |
Carmustine | -0.2552 | 0.0491 |